103 related articles for article (PubMed ID: 17218774)
21. [Expression of estrogen sulfotransferase (EST) gene and bridging integrator protein-1 (BIN1) gene and their significance in breast tissues].
Deng WH; Wu YY; Yang L; Tang WQ; Wang S
Ai Zheng; 2004 Nov; 23(11):1302-5. PubMed ID: 15522178
[TBL] [Abstract][Full Text] [Related]
22. DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.
De Gregoriis G; Ramos JA; Fernandes PV; Vignal GM; Brianese RC; Carraro DM; Monteiro AN; Struchiner CJ; Suarez-Kurtz G; Vianna-Jorge R; de Carvalho MA
Cancer Biol Ther; 2017 Jun; 18(6):439-449. PubMed ID: 28475402
[TBL] [Abstract][Full Text] [Related]
23. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
[TBL] [Abstract][Full Text] [Related]
25. Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer.
Chang MY; Boulden J; Katz JB; Wang L; Meyer TJ; Soler AP; Muller AJ; Prendergast GC
Cancer Res; 2007 Aug; 67(16):7605-12. PubMed ID: 17699764
[TBL] [Abstract][Full Text] [Related]
26. [Expression and significance of Bmi-1 in breast cancer].
Feng Y; Song LB; Guo BH; Liao WT; Li MZ; Liu WL; Zeng MS; Zhang L
Ai Zheng; 2007 Feb; 26(2):154-7. PubMed ID: 17298744
[TBL] [Abstract][Full Text] [Related]
27. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.
Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY
Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897
[TBL] [Abstract][Full Text] [Related]
28. Nodal metastasis signatures in breast cancer.
Park K; Lee JH; Han HH; Mun SG; Kang S; Cha YJ; Koo JS; Kim MJ; Lee HS; Moon J; Cho NH
Pathol Res Pract; 2017 Jun; 213(6):680-687. PubMed ID: 28476377
[TBL] [Abstract][Full Text] [Related]
29. Prognostic analysis of survival in small breast cancers.
Mustafa IA; Cole B; Wanebo HJ; Bland KI; Chang HR
J Am Coll Surg; 1998 May; 186(5):562-9. PubMed ID: 9583697
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
32. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
[TBL] [Abstract][Full Text] [Related]
33. [Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors].
Bi Y; Wei L; Mao HT; Zhang L; Zuo WS
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):749-53. PubMed ID: 19173804
[TBL] [Abstract][Full Text] [Related]
34. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.
Esmailzadeh S; Huang Y; Su MW; Zhou Y; Jiang X
Leukemia; 2015 Jun; 29(6):1402-13. PubMed ID: 25578476
[TBL] [Abstract][Full Text] [Related]
35. Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma.
Zhong X; Hoelz DJ; Kumar HR; Sandoval JA; Rescorla FJ; Hickey RJ; Malkas LH
Pediatr Blood Cancer; 2009 Sep; 53(3):332-7. PubMed ID: 19418541
[TBL] [Abstract][Full Text] [Related]
36. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
37. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
38. Bin1 interacts with and restrains the DNA end-binding protein complex Ku.
Ramalingam A; Farmer GE; Stamato TD; Prendergast GC
Cell Cycle; 2007 Aug; 6(15):1914-8. PubMed ID: 17671430
[TBL] [Abstract][Full Text] [Related]
39. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.
Pyndiah S; Tanida S; Ahmed KM; Cassimere EK; Choe C; Sakamuro D
Sci Signal; 2011 Mar; 4(166):ra19. PubMed ID: 21447800
[TBL] [Abstract][Full Text] [Related]
40. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]